Valion Bio to Sell 1,539 Series B Warrants for $50,000
Valion Bio will sell 1,539 Series B warrants at $1.01 per share for $50,000, according to an SEC filing.
Related stories
ServiceNow shares fall 22% after Q3 profit miss
Shares hit their lowest level since August.
M impact | EQUITY | Oct 29, 2026, 01:35 PM UTC
eBay Shares Rise 1.9% After Q3 Results Beat
M impact | EQUITY | Oct 29, 2026, 01:35 PM UTC
FHLB Cincinnati Announces Third-Quarter 2026 Results
M impact | EQUITY | Oct 29, 2026, 01:35 PM UTC
José Cuervo Shares Sink 8% After Weak Quarterly Report
Shares of Mexican spirits maker José Cuervo fell 8% after a weak quarterly report.
M impact | EQUITY | Oct 29, 2026, 01:35 PM UTC
Report: Microsoft Plans $25 Billion Bond Sale
Microsoft shares are up 0.6% after its Q1 results, as a report says the company plans to raise $25 billion through a bond sale.
M impact | EQUITY | Oct 29, 2026, 01:34 PM UTC
T-Mobile Shares Rise 2.1% After Q3 Results Beat
M impact | EQUITY | Oct 29, 2026, 01:34 PM UTC